Two COVID-19 antivirals get FDA nod for emergency use
Unlike in the case of remdesivir, both the drugs — Pfizer’s paxlovid and Merck’s molnupiravir — are oral pills and
Read More
Year: 2021
Is the current testing, sequencing strategy missing Omicron cases in India?
A November 30, 2021 circular from the health ministry clearly mentions that effective December 1, all passengers arriving from specified
Read More
COVID-19: New Omicron sub-lineage may not further increase transmissibility
Now, based on genome sequence data, scientists have identified a sub-lineage — BA.2 — of Omicron. As a result, the
Read More
How the idea of COVID-19 vaccine protection changed in one year
On this day last year (December 11, 2020), Pfizer’s vaccine for COVID-19 was granted an emergency use authorisation, and exactly
Read More
Does the Omicron variant make a case for COVID-19 booster doses?
At a recent meeting, the National Technical Advisory Group on Immunisation maintained that it was not recommending a booster dose
Read More
Groping in the dark on COVID-19 booster doses
Even when clamour from a few States for booster doses increased once the new variant with higher transmissibility causing a
Read More
COVID-19: Mechanism of blood clots after Oxford vaccine administration found
Thrombosis with thrombocytopenia syndrome is a very rare serious adverse effects following vaccination using chimpanzee adenovirus Y25 (ChAdOx1), human adenovirus
Read More
Criticised if delayed in sharing COVID-19 data, punished for diligently posting data
After the first infection by a new variant — it has 32 mutations in the spike protein alone — was
Read More
Covaxin elicits immune memory to virus up to six months, study finds
The study has been posted on a preprint server medRxiv. Preprints are yet to be peer-reviewed and published in a
Read More
SARS-CoV-2 virus rages in Europe as epicentre shifts
The continent reported nearly two million new cases last week, the highest since the pandemic began, and more than half
Read More
Restrictive voluntary license of COVID-19 antivirals compromises access, says Leena Menghaney
In an email, Leena Menghaney, South Asia Head of Médecins Sans Frontières’s Access Campaign, says that the voluntary license will
Read More
Pfizer’s antiviral Paxlovid is a major advancement potentially for all coronaviruses, says Gagandeep Kang
In an email, Dr. Gagandeep Kang, Professor of Microbiology at CMC Vellore explains the significance of paxlovid antiviral for treatment,
Read More
India falters in administering COVID-19 second dose
No new variant in India According to INSACOG, AY4.2, a Delta variant sublineage, which is slowly increasing in proportion to
Read More